<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/32D1574E-69DF-41D7-A429-067BC62DC26A"><gtr:id>32D1574E-69DF-41D7-A429-067BC62DC26A</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Britton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001424"><gtr:id>463D10DC-4AD4-49C8-BA36-A5D22952FC35</gtr:id><gtr:title>Development of an IBV reverse genetics system based on the pathogenic M41 strain for the identification of regions of the genome involved in virulence</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001424</gtr:grantReference><gtr:abstractText>This project will be involved in the generation of an IBV reverse genetics system based on the virulent M41 strain of IBV. We will use our in house method to modifying the M41 genome to identify regions of the genome involved in pathogenicity/attenuation for the rational attenuation of pathogenicity in a non-reversible manner. We have previously used an IBV reverse genetics system based on the avirulent Beaudette strain to show that introduction of a Spike gene from a virulent isolate modified tropism, did not increase pathogenicity but did induce a protective immune response for protection of chickens challenged with the virulent strain that was used as donor for the S protein. We will replace in the M41 S protein in the M41-based infectious clone with the corresponding S gene from Beaudette. Recombinant IBVs will be assessed for pathogenicity and used in a challenge study to determine whether the Beaudette-derived S gene can be used for protection when used in a different genomic background. Recombinant IBVs that have been recovered from our Beaudette-based infectious clone system were found to be substantially less virulent in 18-day-old embryos; they did not cause a substantial drop in hatchability when compared to IBV vaccine strains and were potential candidates for in ovo vaccination. An amino acid substitution within the replicase Nsp16 protein was identified as a potential change that may be involved in the loss of hatchability associated with IBV vaccines. We will back mutate the mutation in Nsp16 and in collaboration with Intervet determine whether this affects hatchability.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-07-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>157323</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Careers fair</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>41B1E841-6DC7-4C12-83CB-DBD187E899F0</gtr:id><gtr:impact>Students from several schools in the region attended the careers fair where we had a stall. Several students requested information about apprenticeships and were interested in possible careers in science.</gtr:impact><gtr:outcomeId>58b42ecbd5bec3.39594008</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Microbiology Society Avian Focus Meeting (London, UK)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>67715371-4759-463A-9F55-DA414AEB67FB</gtr:id><gtr:impact>I gave a 15 minute oral presentation to an audience of around 80 people. The audience consisted of researchers from many different scientific institutions from different areas of avian research. This was a great opportunity to present to experts in this field and gain novel insights into the project and the possible applications of my work.</gtr:impact><gtr:outcomeId>58c97889ba7d48.58621972</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Reverse genetics seminar (University of Surrey)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A0CC9661-6632-479A-96B9-35B2711DB347</gtr:id><gtr:impact>A seminar was given based upon the reverse genetics system of infectious bronchitis virus. The audience was a group of 10 -15 MSc students from University of Surrey. The students were engaged, asked questions about the research and careers in science. We were asked to repeat the seminar for the next year's intake of students.</gtr:impact><gtr:outcomeId>56ddb710d07e17.06831312</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Positive Strand Viruses Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>01E8B57D-DF43-4B48-B92B-E5113215AE5D</gtr:id><gtr:impact>This was a poster presentation. There were several different poster sessions at the conference allowing a large selection of people to view each poster. The audience included world leaders in my research field and important names from groups all over the world. This gave me the opportunity to discuss my work with other scientists on a one to one basis, leading to generation of new ideas for future experiments and collaborations.</gtr:impact><gtr:outcomeId>58c97b31074fc9.73868772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2010,2013,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teentech</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B3AABA69-B649-4049-B699-8D8B0FF03688</gtr:id><gtr:impact>The annual Teentech student science event in Guildford aims to encourage teenagers to consider science subjects and science careers. Our stand had considerable interest from the schoolchildren who were very enthusiastic.</gtr:impact><gtr:outcomeId>58b42dedb95dc2.61528372</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Compton, West Berkshire)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>39179DAD-D1AE-44E3-B309-A745F574D6E9</gtr:id><gtr:impact>The school visits included working with small groups of a-level biology students demonstrating a technique in the curriculum. They were encouraged to ask us questions about our work and how we use the technique as well as trying it out for themselves.</gtr:impact><gtr:outcomeId>58c97943435033.21804277</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited seminar speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5F00A06D-A76E-41FE-B5BF-EDAA14BAB2AB</gtr:id><gtr:impact>Erica Bickerton was invited to give a seminar at Imperial College London, which sparked questions and discussion afterwards.</gtr:impact><gtr:outcomeId>58b45d57ecdb60.78635083</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Microbiology Society Annual conference (UK)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>24648A76-10A7-4B61-B7B0-7772FB8E99B7</gtr:id><gtr:impact>Poster or oral presentation at Microbiology Society annual conference, a major international event. The participants included researchers from many different areas of science. This provides a platform to promote research to a wider audience as well as discuss the key findings with experts in my own field.</gtr:impact><gtr:outcomeId>58c97a8c61b821.23525372</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1382000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC responsive mode link award</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P019137/1</gtr:fundingRef><gtr:id>148B808C-A0F8-4C7E-BF2D-704794C0B10A</gtr:id><gtr:outcomeId>58c9266de54454.92149363</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Work from this has contributed to a patent</gtr:description><gtr:id>DC0A9558-210D-4679-89E9-628A4C5F79F3</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5457bafe2a1b02.59390729</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This grant has contributed to the development of several rIBVs that have been used in other projects</gtr:description><gtr:exploitationPathways>This grant has contributed to the development of several rIBVs that have been used in other projects</gtr:exploitationPathways><gtr:id>C73749B5-8799-4C90-8D9E-286338334DCE</gtr:id><gtr:outcomeId>5457b9f88caba1.38241447</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.pirbright.ac.uk/our-science/avian-viral-diseases/avian-endemic-viruses</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9ECF3B73-CA9D-4BC3-90F5-8292C7F58D01</gtr:id><gtr:title>Identification of a noncanonically transcribed subgenomic mRNA of infectious bronchitis virus and other gammacoronaviruses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b8b211becaf71125a1293ecc48aa145"><gtr:id>8b8b211becaf71125a1293ecc48aa145</gtr:id><gtr:otherNames>Bentley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>541a9978c75830.03016103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E731B2C-9CE2-4787-BE35-28B8EED8CFCA</gtr:id><gtr:title>Detection of Avian coronavirus infectious bronchitis virus type QX infection in Switzerland.</gtr:title><gtr:parentPublicationTitle>Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35731614bff2c3cf174a59bd1053349"><gtr:id>f35731614bff2c3cf174a59bd1053349</gtr:id><gtr:otherNames>Sigrist B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1040-6387</gtr:issn><gtr:outcomeId>5453b9c1984cd3.68410437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A89885B-8CFE-43B8-A044-03BBB2472418</gtr:id><gtr:title>Recombinant vaccines against infectious bronchitis</gtr:title><gtr:parentPublicationTitle>Avian Pathology Newsletter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a8f669c92c8bc3a4c8e0c72fdf37943"><gtr:id>2a8f669c92c8bc3a4c8e0c72fdf37943</gtr:id><gtr:otherNames>Britton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>545767c636cb97.75763770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD8528B-B32B-49E0-B247-8EB919278F4B</gtr:id><gtr:title>Rational modification of IBV to identify determinants of pathogenicity</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce27b117de22b6680a5c423ba7826f7e"><gtr:id>ce27b117de22b6680a5c423ba7826f7e</gtr:id><gtr:otherNames>Paul Britton (Speaker)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_8797921351140e02a4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BE87ABB-F4D7-4C2E-8129-DE005338C830</gtr:id><gtr:title>Reverse Genetics System for the Avian Coronavirus Infectious Bronchitis Virus.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24b090b425c30262b60624e21838d7a6"><gtr:id>24b090b425c30262b60624e21838d7a6</gtr:id><gtr:otherNames>Bickerton E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>596f7d8bb2fd02.08070291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>805F14B6-6218-4F5E-83D0-0A3975561A26</gtr:id><gtr:title>Infectious Bronchitis Virus as a Vector for the Expression of Heterologous Genes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b8b211becaf71125a1293ecc48aa145"><gtr:id>8b8b211becaf71125a1293ecc48aa145</gtr:id><gtr:otherNames>Bentley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>541a9978811379.72350105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB25DB5-D628-4364-B4EA-C82A8BCCD1E0</gtr:id><gtr:title>Modification of the avian coronavirus infectious bronchitis virus for vaccine development.</gtr:title><gtr:parentPublicationTitle>Bioengineered bugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a8f669c92c8bc3a4c8e0c72fdf37943"><gtr:id>2a8f669c92c8bc3a4c8e0c72fdf37943</gtr:id><gtr:otherNames>Britton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1949-1018</gtr:issn><gtr:outcomeId>5453b9c14b2b49.38263966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2928A657-D29F-42BE-A992-4BB914FBCCCB</gtr:id><gtr:title>The cellular interactome of the coronavirus infectious bronchitis virus nucleocapsid protein and functional implications for virus biology.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79f7b0c552c9c431fdef79da313b07bb"><gtr:id>79f7b0c552c9c431fdef79da313b07bb</gtr:id><gtr:otherNames>Emmott E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5453b9c173a3b7.25709468</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001424</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>